NCT00000857 - A Study to Evaluate the Effects of Interleukin-12 (rhIL-12) in HIV-Positive Patients With CD4 Cell Counts Less Than 50 Cells/mm3 or 300-500 Cells/mm3 | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

June 30, 2001

Conditions

HIV Infections

Interventions

DRUG

Interleukin-12

Trial Locations (16)

NY Univ. HIV/AIDS CRS, New York

Univ. of Rochester ACTG CRS, Rochester

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

Northwestern University CRS, Chicago

Rush Univ. Med. Ctr. ACTG CRS, Chicago

Weiss Memorial Hosp., Chicago

UCLA CARE Center CRS, Los Angeles

Harbor-UCLA Med. Ctr. CRS, Torrance

University of Washington AIDS CRS, Seattle

USC CRS, Los Angeles

Stanford CRS, Palo Alto

Ucsf Aids Crs, San Francisco

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Unc Aids Crs, Chapel Hill

Massachusetts General Hospital ACTG CRS, Boston

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH